Navigation Links
Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
Date:10/23/2008

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2008 financial results after the NASDAQ Global Market closes on Thursday, October 30, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the third quarter 2008 financial results and to provide a corporate update.

The conference call may be accessed by dialing 877.874.1570 for domestic callers and 719.325.4780 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals Third Quarter 2008 Earnings Call." The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being e
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
2. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
5. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
6. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
7. ThreeWire Expands Presence in the Pharmaceutical Arena
8. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
9. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
10. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... leader Yung-Eun Sung has announced that they have ... graphenes which can be applied as high performance ... Sung is both a group leader at the ... Science* (IBS) and a professor at the Seoul ... with regards to the development of relative simplicity, ...
(Date:7/24/2014)... and synthetic processes prefer to settle into equilibriuma ... is within the realm of non-equilibrium conditions where ... in energy and phases, such as temperature fluctuations, ... humans to regulate their body temperature, airplanes to ... activity. , But even though these conditions ...
(Date:7/24/2014)... California (PRWEB) July 24, 2014 ... to advances in modeling lithium-ion battery storage capacity. ... benefit from a theoretical model created at ... University that predicts how carbon components will ... energy storage emphasizes the urgent need for higher-performance ...
(Date:7/24/2014)... Three companies from the angelMD network ... C Competition. Out of 700 competition entrants, Chiron Health, ... semi-final round. In this round twenty teams are invited ... with mentoring from thought-leaders and medical entrepreneurs from all ... angelMD commitment to the Livestrong vision around the Big ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2
... RADI Medical Systems today,announced improvements to their ... which will begin shipments immediately., (Photo: ... generation of the PressureWire(R) Certus features a ... key,advantages for physicians. The new large entry ...
... /Xinhua-PRNewswire-FirstCall/ -- China-Biotics,Inc. (OTC Bulletin Board: CHBT) ... in the manufacture, research, development,marketing and distribution ... China-Biotics, Chief Technology Officer, has been invited ... Annual Food Safety Technology Forum,2008 (the "Forum")., ...
... Milestones and Maintain ... Commitment to Strategy, ... Inc.,(TSX: MGI, OTC: MGIFF), a clinical-stage developer of drugs for ... shareholders,for the purpose of acquiring control of MIGENIX,s board of ...
Cached Biology Technology:RADI Medical Systems Launches Next Generation PressureWire(R) Certus 2China-Biotics, Inc. to Present at China's 3rd Annual Food Safety Technology Forum 2008 2China-Biotics, Inc. to Present at China's 3rd Annual Food Safety Technology Forum 2008 3MIGENIX Corporate Update and Requisition of Special Meeting 2MIGENIX Corporate Update and Requisition of Special Meeting 3MIGENIX Corporate Update and Requisition of Special Meeting 4MIGENIX Corporate Update and Requisition of Special Meeting 5MIGENIX Corporate Update and Requisition of Special Meeting 6MIGENIX Corporate Update and Requisition of Special Meeting 7MIGENIX Corporate Update and Requisition of Special Meeting 8
(Date:7/25/2014)... people lived on the land now called California, and ... availability of plants they used for food, fuel, tools, ... maintain desired habitat and natural resources. , Frank Lake, ... Station, will lead a field trip to ... Society of America,s 99th Annual Meeting, in Sacramento, Cal. ...
(Date:7/25/2014)... 2014)The link between autism and disrupted brain development ... the disease, and is largely unknown. However, thanks ... Initiative (SFARI), George Washington University (GW) researcher Anthony-Samuel ... integrative and in-depth answers to these key questions ... LaMantia, professor of pharmacology and physiology at the ...
(Date:7/25/2014)... engineering at the University of Houston, has written ... organ development., "Introduction to Tissue Engineering: Applications and ... the field of artificial organ development. Metin Akay, ... UH, served as a series editor on the ... published books on the subject of growing artificial ...
Breaking Biology News(10 mins):Fire ecology manipulation by California native cultures 2Fire ecology manipulation by California native cultures 3GW researcher receives grant to answer the how and why of autism during development 2University of Houston researcher publishes textbook on tissue engineering 2
... cells called macrophages can destroy tumor cells by producing ... the environment inside the tumor somehow halts this production ... promote tumor growth. The new study ... switch. This protein normally stimulates protective inflammation. But in ...
... ability every aging Hollywood star would envy: they can ... the May 19 issue of the Journal of ... London, UK) and collogues have pinned down a protein ... that might help researchers understand why myelin production falters ...
... Fla. (May 19, 2008) The current issue of ... by researchers seeking new ways to treat Parkinsons disease ... and slowed physical movements related to insufficient levels of ... by using primate models to examine the potential therapy ...
Cached Biology News:Neural cell transplants may help those with Parkinson's disease 2Neural cell transplants may help those with Parkinson's disease 3
... Todays research and biologic production demands ... guesswork to confirming viable cell populations. Therefore, ... cells must be determined accurately and precisely. ... an automatic and cost effective means to ...
... SureLINK Bioconjugation Kit provides a powerful yet ... and nuceleic acids. The kit provides the ... reagents for quantifying conjugation efficiencies. It enables ... biotin and other tags with a variety ...
... the sensitivity and versatility you expect from ... counting with selected photomultipliers ensure superior sensitivity ... with up to 2 reagent injectors the ... assays as well as other luminescence applications ...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Biology Products: